Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 2/5/21 → 12/31/24 |
Funding
- Janssen Vaccines and Prevention BV: $1,185,594.00
Covid 19: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older
- Greenberg, Richard (PI)
- Kern, Philip (CoI)
- Simmons, Christopher (CoI)
- Caudill, Timothy (Former CoI)
- Englert, Brooke (Former CoI)